Chronic liver disease in the extremely elderly of 80 years or more: Clinical characteristics, prognosis and patient survival analysis

Yujin Hoshida, Kenji Ikeda, Masahiro Kobayashi, Yoshiyuki Suzuki, Akihito Tsubota, Satoshi Saitoh, Yasuji Arase, Mizuho Kobayashi, Naoya Murashima, Kazuaki Chayama, Hiromitsu Kumada

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Background/Aims: This study aimed to elucidate the clinical characteristics of patients with chronic liver disease aged 80 years or more, especially the factors affecting prognosis and carcinogenesis. Methods: A total of 135 patients aged 80 years or above were divided into chronic liver disease without cirrhosis (non-LC) and cirrhosis (LC) groups according to the severity of fibrosis, and the clinical characteristics and prognoses were evaluated. Results: Seventy-three (54.1%) of 135 patients were in the LC group and 79 patients (58.5%) had hepatitis C virus. Various concomitant diseases were seen in 122 patients (90.4%). Liver-related deaths occurred in only 19 (36.5%) of 52 patients who died during observation, although 28 patients (53.8%) had liver cancer at the time of death. Cumulative survival rates in the non-LC and the LC groups were 85.7% and 58.8% at the 5th year, and 69.4% and 19.4% at the 9th year, respectively. Cumulative liver cancer appearance rates in the non-LC and the LC groups were 1.6% and 6.1% at the 1st year, 12.4% and 19.9% at the 5th year, and 12.4% and 32.0% at the 7th year, respectively. A multivariate Cox regression analysis revealed that the presence of liver cancer (p = 0.0001), platelet count (p = 0.0242), and fibrotic stage (p = 0.0118) were independently associated with survival period, and alfa-fetoprotein (p = 0.0194) and bilirubin (p = 0.0282) were independently associated with carcinogenesis. Conclusions: Cirrhosis is the major risk factor affecting the prognosis. On the other hand, we must pay more attention to concomitant diseases specific to advanced age.

Original languageEnglish (US)
Pages (from-to)860-866
Number of pages7
JournalJournal of Hepatology
Volume31
Issue number5
DOIs
StatePublished - Nov 1999
Externally publishedYes

Fingerprint

Survival Analysis
Liver Diseases
Chronic Disease
Fibrosis
Liver Neoplasms
Carcinogenesis
alpha-Fetoproteins
Platelet Count
Bilirubin
Hepacivirus
Survival Rate
Regression Analysis
Observation
Survival
Liver

Keywords

  • Chronic liver disease
  • Extremely elderly patients
  • Liver cancer appearance rate
  • Survival analysis

ASJC Scopus subject areas

  • Hepatology

Cite this

Chronic liver disease in the extremely elderly of 80 years or more : Clinical characteristics, prognosis and patient survival analysis. / Hoshida, Yujin; Ikeda, Kenji; Kobayashi, Masahiro; Suzuki, Yoshiyuki; Tsubota, Akihito; Saitoh, Satoshi; Arase, Yasuji; Kobayashi, Mizuho; Murashima, Naoya; Chayama, Kazuaki; Kumada, Hiromitsu.

In: Journal of Hepatology, Vol. 31, No. 5, 11.1999, p. 860-866.

Research output: Contribution to journalArticle

Hoshida, Y, Ikeda, K, Kobayashi, M, Suzuki, Y, Tsubota, A, Saitoh, S, Arase, Y, Kobayashi, M, Murashima, N, Chayama, K & Kumada, H 1999, 'Chronic liver disease in the extremely elderly of 80 years or more: Clinical characteristics, prognosis and patient survival analysis', Journal of Hepatology, vol. 31, no. 5, pp. 860-866. https://doi.org/10.1016/S0168-8278(99)80287-6
Hoshida, Yujin ; Ikeda, Kenji ; Kobayashi, Masahiro ; Suzuki, Yoshiyuki ; Tsubota, Akihito ; Saitoh, Satoshi ; Arase, Yasuji ; Kobayashi, Mizuho ; Murashima, Naoya ; Chayama, Kazuaki ; Kumada, Hiromitsu. / Chronic liver disease in the extremely elderly of 80 years or more : Clinical characteristics, prognosis and patient survival analysis. In: Journal of Hepatology. 1999 ; Vol. 31, No. 5. pp. 860-866.
@article{93d4ddbd1b8245ab91c741049c97297c,
title = "Chronic liver disease in the extremely elderly of 80 years or more: Clinical characteristics, prognosis and patient survival analysis",
abstract = "Background/Aims: This study aimed to elucidate the clinical characteristics of patients with chronic liver disease aged 80 years or more, especially the factors affecting prognosis and carcinogenesis. Methods: A total of 135 patients aged 80 years or above were divided into chronic liver disease without cirrhosis (non-LC) and cirrhosis (LC) groups according to the severity of fibrosis, and the clinical characteristics and prognoses were evaluated. Results: Seventy-three (54.1{\%}) of 135 patients were in the LC group and 79 patients (58.5{\%}) had hepatitis C virus. Various concomitant diseases were seen in 122 patients (90.4{\%}). Liver-related deaths occurred in only 19 (36.5{\%}) of 52 patients who died during observation, although 28 patients (53.8{\%}) had liver cancer at the time of death. Cumulative survival rates in the non-LC and the LC groups were 85.7{\%} and 58.8{\%} at the 5th year, and 69.4{\%} and 19.4{\%} at the 9th year, respectively. Cumulative liver cancer appearance rates in the non-LC and the LC groups were 1.6{\%} and 6.1{\%} at the 1st year, 12.4{\%} and 19.9{\%} at the 5th year, and 12.4{\%} and 32.0{\%} at the 7th year, respectively. A multivariate Cox regression analysis revealed that the presence of liver cancer (p = 0.0001), platelet count (p = 0.0242), and fibrotic stage (p = 0.0118) were independently associated with survival period, and alfa-fetoprotein (p = 0.0194) and bilirubin (p = 0.0282) were independently associated with carcinogenesis. Conclusions: Cirrhosis is the major risk factor affecting the prognosis. On the other hand, we must pay more attention to concomitant diseases specific to advanced age.",
keywords = "Chronic liver disease, Extremely elderly patients, Liver cancer appearance rate, Survival analysis",
author = "Yujin Hoshida and Kenji Ikeda and Masahiro Kobayashi and Yoshiyuki Suzuki and Akihito Tsubota and Satoshi Saitoh and Yasuji Arase and Mizuho Kobayashi and Naoya Murashima and Kazuaki Chayama and Hiromitsu Kumada",
year = "1999",
month = "11",
doi = "10.1016/S0168-8278(99)80287-6",
language = "English (US)",
volume = "31",
pages = "860--866",
journal = "Journal of Hepatology",
issn = "0168-8278",
publisher = "Elsevier",
number = "5",

}

TY - JOUR

T1 - Chronic liver disease in the extremely elderly of 80 years or more

T2 - Clinical characteristics, prognosis and patient survival analysis

AU - Hoshida, Yujin

AU - Ikeda, Kenji

AU - Kobayashi, Masahiro

AU - Suzuki, Yoshiyuki

AU - Tsubota, Akihito

AU - Saitoh, Satoshi

AU - Arase, Yasuji

AU - Kobayashi, Mizuho

AU - Murashima, Naoya

AU - Chayama, Kazuaki

AU - Kumada, Hiromitsu

PY - 1999/11

Y1 - 1999/11

N2 - Background/Aims: This study aimed to elucidate the clinical characteristics of patients with chronic liver disease aged 80 years or more, especially the factors affecting prognosis and carcinogenesis. Methods: A total of 135 patients aged 80 years or above were divided into chronic liver disease without cirrhosis (non-LC) and cirrhosis (LC) groups according to the severity of fibrosis, and the clinical characteristics and prognoses were evaluated. Results: Seventy-three (54.1%) of 135 patients were in the LC group and 79 patients (58.5%) had hepatitis C virus. Various concomitant diseases were seen in 122 patients (90.4%). Liver-related deaths occurred in only 19 (36.5%) of 52 patients who died during observation, although 28 patients (53.8%) had liver cancer at the time of death. Cumulative survival rates in the non-LC and the LC groups were 85.7% and 58.8% at the 5th year, and 69.4% and 19.4% at the 9th year, respectively. Cumulative liver cancer appearance rates in the non-LC and the LC groups were 1.6% and 6.1% at the 1st year, 12.4% and 19.9% at the 5th year, and 12.4% and 32.0% at the 7th year, respectively. A multivariate Cox regression analysis revealed that the presence of liver cancer (p = 0.0001), platelet count (p = 0.0242), and fibrotic stage (p = 0.0118) were independently associated with survival period, and alfa-fetoprotein (p = 0.0194) and bilirubin (p = 0.0282) were independently associated with carcinogenesis. Conclusions: Cirrhosis is the major risk factor affecting the prognosis. On the other hand, we must pay more attention to concomitant diseases specific to advanced age.

AB - Background/Aims: This study aimed to elucidate the clinical characteristics of patients with chronic liver disease aged 80 years or more, especially the factors affecting prognosis and carcinogenesis. Methods: A total of 135 patients aged 80 years or above were divided into chronic liver disease without cirrhosis (non-LC) and cirrhosis (LC) groups according to the severity of fibrosis, and the clinical characteristics and prognoses were evaluated. Results: Seventy-three (54.1%) of 135 patients were in the LC group and 79 patients (58.5%) had hepatitis C virus. Various concomitant diseases were seen in 122 patients (90.4%). Liver-related deaths occurred in only 19 (36.5%) of 52 patients who died during observation, although 28 patients (53.8%) had liver cancer at the time of death. Cumulative survival rates in the non-LC and the LC groups were 85.7% and 58.8% at the 5th year, and 69.4% and 19.4% at the 9th year, respectively. Cumulative liver cancer appearance rates in the non-LC and the LC groups were 1.6% and 6.1% at the 1st year, 12.4% and 19.9% at the 5th year, and 12.4% and 32.0% at the 7th year, respectively. A multivariate Cox regression analysis revealed that the presence of liver cancer (p = 0.0001), platelet count (p = 0.0242), and fibrotic stage (p = 0.0118) were independently associated with survival period, and alfa-fetoprotein (p = 0.0194) and bilirubin (p = 0.0282) were independently associated with carcinogenesis. Conclusions: Cirrhosis is the major risk factor affecting the prognosis. On the other hand, we must pay more attention to concomitant diseases specific to advanced age.

KW - Chronic liver disease

KW - Extremely elderly patients

KW - Liver cancer appearance rate

KW - Survival analysis

UR - http://www.scopus.com/inward/record.url?scp=0032721674&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032721674&partnerID=8YFLogxK

U2 - 10.1016/S0168-8278(99)80287-6

DO - 10.1016/S0168-8278(99)80287-6

M3 - Article

C2 - 10580583

AN - SCOPUS:0032721674

VL - 31

SP - 860

EP - 866

JO - Journal of Hepatology

JF - Journal of Hepatology

SN - 0168-8278

IS - 5

ER -